Are you on a successful path to ending tuberculosis (TB)? This group of indicators will help you answer that question by providing standardized comparisons across the United States Agency for International Development’s (USAID’s) TB priority countries. These indicators are intended to help measure each outcome and impact; help decision-makers answer questions; and measure progress towards global and individual country targets.
PBMEF Indicators
Core Indicators
Reach
[CH-5] Childhood TB Notifications 
Sustain
Extended Indicators
Active Case Finding (AF)
Childhood TB (CH)
[CH-7] Childhood TB Detection
Contact Investigation (CI)
Drug-Resistant TB Notifications (RN)
[RN-2] DR-TB Case Detection
Drug-Resistant TB Treatment Success (RS)
Presumptive TB (PS)
Prevention (PV)
Private Sector (PR)
Sustainability (SN)
[SN-33] Approval Process Efficiency
[SN- 33A] Approval Process Efficiency – A
[SN- 33B] Approval Process Efficiency-B
[SN- 26B] Availability of Final JPR/JMM Report
[SN- 41C] C – TB Gender Assessment Report
[SN-4] Domestic Funding for Drugs
[SN-36] Effective NTP Capacity
[SN-41] Inclusiveness of Gender
[SN- 26A] JPR/JMM was Conducted Recently
[SN-28] Mandatory Notification
[SN-35] NTP Capacity
[SN-14] Pediatric TB Treatment
[SN-20] Regimen for TBI
[SN-8] Social Protection
[SN-18] TB Screening
[SN-32] TB Stigma Reduction
[SN-19] TBI TPT
[SN-12] Universal DST
TB Detection (DT)
[DT-1] TB Case Notifications 
TB Preventive Treatment (PT)
[PT-12] Percent of PLHIV Completed TPT
[PT-13] Percent TPT Patients LTFU
TB Treatment Success (SS)
[SS-4] TB Treatment Outcome: LTFU 
TB/HIV (TH)
[TH-28] PLHIV with TB Who Have CD4 > 100
[TH-29] PLHIV with TB Who Have CD4 > 350